Diabetes mellitus (DM) is a global health issue in the twenty-first century, and there are numerous challenges in preventing and alleviating its chronic complications. The herb Epimedium has be
Fibroblast growth factor 21 (FGF21) is a regulator of glucose and lipid metabolism. It has been widely considered as a promising candidate for the treatment of type 2 diabetes mellitus (T2DM) and othe
Abnormal Glucose Tolerance Treatment comes with extensive industry analysis of development components, patterns, flows, and sizes. The report calculates present and past market values to forecast pote
Background: Attainment of therapeutic goals in Type 2 Diabetes Mellitus (T2DM) necessitates the rational use of drugs, given the wide options available and the presence of co-morbid diseases. Objec